Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Purchased by Captrust Financial Advisors

Captrust Financial Advisors raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 66.5% in the 4th quarter, HoldingsChannel reports. The fund owned 12,784 shares of the company’s stock after acquiring an additional 5,108 shares during the period. Captrust Financial Advisors’ holdings in Acadia Healthcare were worth $507,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in ACHC. Lindbrook Capital LLC boosted its holdings in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. raised its position in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after acquiring an additional 301 shares during the last quarter. Signaturefd LLC grew its position in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after acquiring an additional 1,004 shares during the period. Finally, Fifth Third Bancorp increased its stake in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after acquiring an additional 454 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $26.15 on Monday. The firm has a fifty day simple moving average of $26.19 and a 200-day simple moving average of $35.49. The company has a market capitalization of $2.41 billion, a PE ratio of 8.57, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. During the same period in the prior year, the company posted $0.84 EPS. The firm’s revenue for the quarter was up .3% on a year-over-year basis. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on ACHC shares. Guggenheim began coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective on the stock. Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Bank of America dropped their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Finally, Mizuho decreased their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.